Duymelinck C, Deng J T, Dauwe S E, De Broe M E, Verpooten G A
Department of Nephrology-Hypertension, University of Antwerp, Belgium.
Kidney Int. 1998 Sep;54(3):804-18. doi: 10.1046/j.1523-1755.1998.00050.x.
Chronic cyclosporine A (CsA)-induced nephropathy is histologically characterized by tubular lesions, the interstitial recruitment of inflammatory cells, arteriolopathy and focal interstitial fibrosis. Recent studies show that the intrarenal inhibition of matrix degradation and recruitment of monocytes/ macrophages into the kidney plays a critical role in the development of renal interstitial fibrosis.
We examined the expression of components of the matrix metalloproteinase (MMP) system and plasminogen activator inhibitor type-1 (PAI-1) in kidneys from rats injected daily s.c. during three weeks with CsA (10, 15 or 20 mg CsA/kg body wt) or vehicle solution.
In all CsA-treated rats, serum creatinine levels were significantly elevated compared to control levels. The extent of CsA-induced atrophy was not influenced by the dosage during a three-week CsA treatment. The administration of CsA did not significantly increase total cortical interstitial collagen deposition, whereas alpha-smooth muscle actin expression was significantly increased in all CsA-treated rats. Analysis of the different subpopulations of inflammatory cells recruited into the chronically injured kidney revealed a marked influx of macrophages into fibrotic cortical foci of CsA-treated rats. The number of cortical macrophages was highest in the group receiving the highest CsA dose. PAI-1 antigen, present in proximal tubular lysosomes in kidneys from all experimental groups, stained very intensely in atrophic tubules in CsA-treated rats. Both stromelysin and interstitial collagenase mRNA were expressed in the kidneys of control rats, but their message transcription remained unaltered after CsA treatment. In contrast, the expression of tissue inhibitor of matrix metalloproteinase type 1 (TIMP-1) was significantly increased after CsA treatment. TIMP-1 mRNA was undetectable in renal sections from sodium-depleted vehicle-treated animals using the in situ hybridization (ISH) technique. ISH of selected renal sections of CsA-treated rats identified the cells responsible for the increased TIMP-1 message transcription after CsA administration, mainly as interstitial cells and also as visceral and parietal epithelial cells.
These results suggest that the locally increased expression of TIMP-1 rather than a decrease of matrix metalloprotease expression, contributes to the development of CsA-induced focal interstitial fibrosis in the rat.
慢性环孢素A(CsA)诱导的肾病在组织学上的特征为肾小管病变、炎症细胞的间质募集、小动脉病变和局灶性间质纤维化。最近的研究表明,肾内基质降解的抑制以及单核细胞/巨噬细胞向肾脏的募集在肾间质纤维化的发展中起关键作用。
我们检测了连续三周每天皮下注射CsA(10、15或20 mg CsA/千克体重)或赋形剂溶液的大鼠肾脏中基质金属蛋白酶(MMP)系统成分和纤溶酶原激活物抑制剂1型(PAI-1)的表达。
与对照水平相比,所有经CsA处理的大鼠血清肌酐水平均显著升高。在为期三周的CsA治疗期间,CsA诱导的萎缩程度不受剂量影响。给予CsA并未显著增加皮质间质胶原的总沉积,而在所有经CsA处理的大鼠中,α-平滑肌肌动蛋白表达显著增加。对募集到慢性损伤肾脏中的不同炎症细胞亚群的分析显示,巨噬细胞大量流入经CsA处理大鼠的纤维化皮质病灶。接受最高CsA剂量的组中皮质巨噬细胞数量最多。所有实验组大鼠肾脏近端肾小管溶酶体中存在的PAI-1抗原,在经CsA处理的大鼠萎缩肾小管中染色非常强烈。基质溶解素和间质胶原酶mRNA在对照大鼠肾脏中均有表达,但经CsA处理后其信息转录未改变。相反,基质金属蛋白酶1型组织抑制剂(TIMP-1)的表达在CsA处理后显著增加。使用原位杂交(ISH)技术在接受赋形剂处理的低钠动物的肾切片中未检测到TIMP-1 mRNA。对经CsA处理大鼠的选定肾切片进行ISH分析,确定了CsA给药后导致TIMP-1信息转录增加的细胞,主要为间质细胞以及脏层和壁层上皮细胞。
这些结果表明,TIMP-1的局部表达增加而非基质金属蛋白酶表达降低,促成了大鼠CsA诱导的局灶性间质纤维化的发展。